Published in
Elsevier, Oral Oncology, 5(49), p. 461-467, 2013
DOI: 10.1016/j.oraloncology.2012.12.016
Links
- Elsevier
- ORCID
- [www.ncbi.nlm.nih.gov] | PDF
- [europepmc.org] | PDF
- [www.researchgate.net] | PDF
- [www.ncbi.nlm.nih.gov] | PDF
Tools
A phase II study of temsirolimus and erlotinib in patients with recurrent and/or metastatic, platinum-refractory head and neck squamous cell carcinoma
Journal article published in 2013 by
Julie E. Bauman,
Hugo Arias-Pulido,
Sang-Joon Lee,
M. Houman Fekrazad,
M. Houman Fekrazad,
Hiroyuki Ozawa,
Elana Fertig 
,
Jason Howard,
Justin Bishop,
Hao Wang,
Garth T. Olson,
Michael J. Spafford,
Dennie V. Jones,
Christine H. Chung
,
Jason Howard,
Justin Bishop,
Hao Wang,
Garth T. Olson,
Michael J. Spafford,
Dennie V. Jones,
Christine H. Chung
This paper is available in a repository.
Full text: Download
Published version:
archiving forbidden
Data provided by 